Last reviewed · How we verify
Leuprolide Oral Tablet 4-mg BID
Leuprolide Oral Tablet 4-mg BID is a Small molecule drug developed by Enteris BioPharma Inc.. It is currently in Phase 2 development. Also known as: Ovarest™ 4.0 mg.
At a glance
| Generic name | Leuprolide Oral Tablet 4-mg BID |
|---|---|
| Also known as | Ovarest™ 4.0 mg |
| Sponsor | Enteris BioPharma Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss (PHASE2)
- ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer (PHASE2)
- Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer (PHASE1)
- Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer (PHASE2)
- A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers (PHASE2)
- The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Leuprolide Oral Tablet 4-mg BID CI brief — competitive landscape report
- Leuprolide Oral Tablet 4-mg BID updates RSS · CI watch RSS
- Enteris BioPharma Inc. portfolio CI
Frequently asked questions about Leuprolide Oral Tablet 4-mg BID
What is Leuprolide Oral Tablet 4-mg BID?
Leuprolide Oral Tablet 4-mg BID is a Small molecule drug developed by Enteris BioPharma Inc..
Who makes Leuprolide Oral Tablet 4-mg BID?
Leuprolide Oral Tablet 4-mg BID is developed by Enteris BioPharma Inc. (see full Enteris BioPharma Inc. pipeline at /company/enteris-biopharma-inc).
Is Leuprolide Oral Tablet 4-mg BID also known as anything else?
Leuprolide Oral Tablet 4-mg BID is also known as Ovarest™ 4.0 mg.
What development phase is Leuprolide Oral Tablet 4-mg BID in?
Leuprolide Oral Tablet 4-mg BID is in Phase 2.
Related
- Manufacturer: Enteris BioPharma Inc. — full pipeline
- Also known as: Ovarest™ 4.0 mg
- Compare: Leuprolide Oral Tablet 4-mg BID vs similar drugs
- Pricing: Leuprolide Oral Tablet 4-mg BID cost, discount & access